Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Low levels of tenuazonic acid can severely damage vital organs.

Controlling transposable elements is crucial for successful tissue regeneration.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

Tofacitinib can cause a rare rash called SDRIFE, which resolves after stopping the drug.

Tofacitinib taken by mouth helps treat hair loss in children.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Serum ferritin can help diagnose Telogen Effluvium.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Topical tacalcitol ointment can help improve symptoms of EFFC.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.